Work

Clinicopathological Features Among Patients With Advanced Human Epidermal Growth Factor–2-Positive Breast Cancer With Prolonged Clinical Benefit to First-Line Trastuzumab-Based Therapy: A Retrospective Cohort Study

Year: 2013

Type: article

Study design: Observational Study

Source: Clinical Breast Cancer

DOI: 10.1016/j.clbc.2013.02.010

Authors: Ines Vaz-Luis, Davinia Seah, Erin M. Olson, Nikhil Wagle, Otto Metzger-Filho, Jessica Sohl, Georgia Litsas, Harold J. Burstein, Ian E. Krop, Eric P. Winer, Nancy U. Lin

Institutions: Dana-Farber Cancer Institute, Instituto de Medicina Molecular João Lobo Antunes, The Ohio State University

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Cancer Institute, National Center for Research Resources

Awards: Harvard Clinical and Translational Science Center (UL1), Dana-Farber/Harvard SPORE in Breast Cancer, Physician Scientist Training in Cancer Research, OSU K12 Training Grant in Oncology

OpenAlex ID: W2078140185

FWCI: 2.141

Cites: 32

Cited by: 27

Related to: 10